Alzheimer Disease Ethics - Informed Consent and Related Issues in Clinical Trials: Results of a Survey among the Members of the Research Ethics Committees in Sweden

International Psychogeriatrics

Volumn 15, Issue 2, 2003, Pages 157-170

  Peterson, Gunbrith ^a   Wallin, Anders ^b  

^a Janssen Cilag   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alzheimer's disease; Dementia; Informed consent; Research ethics

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ATTITUDE; BIOMEDICINE; DECISION MAKING; FEMALE; HEALTH SURVEY; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; MEDICAL ETHICS; MEDICAL RESEARCH; MORALITY; QUESTIONNAIRE; SWEDEN;

BIOMEDICAL AND BEHAVIORAL RESEARCH; EMPIRICAL APPROACH;

ADULT; AGED; ALZHEIMER DISEASE; ATTITUDE OF HEALTH PERSONNEL; CLINICAL TRIALS; COMORBIDITY; DATA COLLECTION; ETHICS COMMITTEES; ETHICS, MEDICAL; ETHICS, RESEARCH; FEMALE; HUMANS; INFORMED CONSENT; LEGAL GUARDIANS; MALE; MENTAL COMPETENCY; MIDDLE AGED; PATIENT PARTICIPATION; PATIENT SELECTION; PSYCHOTIC DISORDERS; SWEDEN;

EID: 0242287098     PISSN: 10416102     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1041610203008846     Document Type: Article

References (21)

1. Baskin, S. A., Morris, J., Ahronheim, J. C., Meier, D. E., & Morrison, R. S. (1998). Barriers to obtaining consent in dementia research: Implications for surrogate decision-making. Journal of the American Geriatrics Society, 46, 287-290.
2. The Belmont Report. (1979, April 18). Ethical principles and guidelines for the protection of human subjects of research. The National Commission for the Protection of Human Subjects of Biomedical and Behaviour Research. Washington, DC: U.S. Government Printing Office.
3. Blennow, K., Minthon, L., & Wallin, A. (2000). New discoveries on Alzheimer disease: New biochemical markers can hopefully improve diagnosis. Lakartidningen (Sweden), 97, 6-10.
4. Blennow, K., & Wallin, A. (2000). CSF tau and β-amyloid. In N. Qizilbash, L. Schneider, H. Chui, et al. (Eds.), Evidence based dementia. Oxford, England: Blackwell Science.
5. Brodaty, H., Gresham, M., & Luscombe, C. (1997). The Prince Henry dementia caregivers' training programme. International Journal of Geriatric Psychiatry, 12, 183-192.
6. Convention for the Protection of Human Rights and Dignity of the Human Being with Regard to the Application of Biology and Medicine: Convention on Human Rights and Biomedicine. (1997). Oviedo 4.IV, Council of Europe.
7. Dukoff, R., & Sunderland, T. (1997). Durable power of attorney and informed consent with Alzheimer's disease patients: A clinical study. American Journal of Psychiatry, 154, 1070-1075.
8. Fratiglioni, L., Grut, M., Forsell, Y., Viitanen, M., Grafstrom, N., et al. (1991). Prevalence of Alzheimer's disease and other dementias in an elderly urban population: Relationship with age, sex, and education. Neurology, 41, 1886-1892.
9. High, D. M., Whitehouse, P. J., Post, S. G., & Berg, L. (1994). Guidelines for addressing ethical and legal issues in Alzheimer disease research. Alzheimer Disease and Associated Disorders, 8, 66-74.
10. Kapp, M. B. (1994). Proxy decision-making in Alzheimer's disease research: Durable power of attorney, guardianship, and other alternatives. Alzheimer Disease and Associated Disorders, 8, 28-37.
11. Karlawish, J. H. T., & Whitehouse, P. (1998). Is the placebo control obsolete in a world after donepezil and vitamin E? Archives of Neurology, 55, 1420-1424.
12. Kawas, C. H., Clark, C. M., Farlow, M. R., Knopman, D. S., Marson, D., et al. (1999). Clinical trials in Alzheimer disease: Debate of the use of placebo controls. Alzheimer Disease and Associated Disorders, 13, 124-129.
13. LeBlang, T., & Kirchner, J. L. (1996). Informed consent and Alzheimer disease research: Institutional Review Board policies and practices. In R. Becker & E. Giacobini (Eds.), Alzheimer disease: From molecular biology to therapy (pp. 529-534). Boston: Birkhäuser.
14. Marson, D., & Harell, L. (1999). Executive dysfunction and loss of capacity to consent to medical treatment in patients with Alzheimer's disease. Seminars in Clinical Neuropsychiatry, 4, 41-49.
15. Mittelman, M. S., Ferris, S. H., Steinberg, G., Shulman, E., Mackell, J. A., et al. (1993). An intervention that delays institutionalisation of Alzheimer's disease patients: Treatment of spouse-caregivers. The Gerontologist, 3, 730-740.
16. Norberg, A., Sandman, P. O., & Winblad, B. (1985). Ethical considerations in research of demented patients. Lakartidningen (Sweden), 82, 4528-4530.
17. Resau, L. S. (1995). Obtaining informed consent in Alzheimer's research. Journal of Neuroscience Nursing, 27, 57-60.
18. Post, S. (Ed.). (1995). International commentaries on "Guidelines for addressing ethical and legal issues in Alzheimer disease research." Alzheimer Disease and Associated Disorders, 9, 188-192.
19. Sugarman, J., Cain, C., Wallace, R., & Welsh-Bohmer, K. A. (2001). How proxies make decisions about research for patients with Alzheimer's disease. Journal of the American Geriatrics Society, 49, 1110-1118.
20. The Swedish Medical Research Council. (1996). Guidelines for ethical evaluation of medical research involving human subjects. The policy and organization of research ethics in Sweden. Stockholm, Sweden: Author.
21. World Medical Association. (2000). Declaration of Helsinki: Ethical principles for medical research involving human subjects. Journal of Postgraduate Medicine, 48, 206-208.